A Real-World Analysis of Post-Marketing Surveillance Data Assessing the Incidence of Hyperkalemia or Acute Kidney Injury in Patients on Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin-Receptor Blockers

A Real-World Analysis of Post-Marketing Surveillance Data Assessing the Incidence of Hyperkalemia or Acute Kidney Injury in Patients on Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin-Receptor Blockers

Background: The widely used Renin-angiotensin-aldosterone system inhibitor (RASI) may increase the risk of hyperkalemia and acute kidney injury (AKI). We aimed to analyze the RASI-related AKI or hyperkalemia reported in the Food and Drug Administration’s Adverse Event Reporting System (FAERS) databa...

Full description

Bibliographic Details
Main Authors: Yining Wang, Qidong Ren, HuiTing Luo, Gang Chen, Bin Zhao, Xuemei Li
Format: Article
Language:English
Published: IMR Press 2023-04-01
Series:Reviews in Cardiovascular Medicine
Subjects:
acei
arb
hyperkalemia
acute kidney injury
faers database
Online Access:https://www.imrpress.com/journal/RCM/24/4/10.31083/j.rcm2404107

Internet

https://www.imrpress.com/journal/RCM/24/4/10.31083/j.rcm2404107

Similar Items